What should we report? Lessons learnt from the development and implementation of serious adverse event reporting procedures in non-pharmacological trials in palliative care
information for practice - open access journal articles,
Serious adverse event reporting guidelines have largely been developed for pharmaceutical trials. There is evidence that…